Literature DB >> 27840024

Intracranial stimulation for children with epilepsy.

Antonio Valentín1, Richard P Selway2, Meriem Amarouche2, Nilesh Mundil2, Ismail Ughratdar2, Leila Ayoubian3, David Martín-López4, Farhana Kazi5, Talib Dar3, Diego Jiménez-Jiménez6, Elaine Hughes7, Gonzalo Alarcón8.   

Abstract

OBJECTIVES: To evaluate the efficacy of intracranial stimulation to treat refractory epilepsy in children.
METHODS: This is a retrospective analysis of a pilot study on all 8 children who had intracranial electrical stimulation for the investigation and treatment of refractory epilepsy at King's College Hospital between 2014 and 2015. Five children (one with temporal lobe epilepsy and four with frontal lobe epilepsy) had subacute cortical stimulation (SCS) for a period of 20-161 h during intracranial video-telemetry. Efficacy of stimulation was evaluated by counting interictal discharges and seizures. Two children had thalamic deep brain stimulation (DBS) of the centromedian nucleus (one with idiopathic generalized epilepsy, one with presumed symptomatic generalized epilepsy), and one child on the anterior nucleus (right fronto-temporal epilepsy). The incidence of interictal discharges was evaluated visually and quantified automatically.
RESULTS: Among the three children with DBS, two had >60% improvement in seizure frequency and severity and one had no improvement. Among the five children with SCS, four showed improvement in seizure frequency (>50%) and one chid did not show improvement. Procedures were well tolerated by children.
CONCLUSION: Cortical and thalamic stimulation appear to be effective and well tolerated in children with refractory epilepsy. SCS can be used to identify the focus and predict the effects of resective surgery or chronic cortical stimulation. Further larger studies are necessary.
Copyright © 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cortical stimulation; DBS; Deep brain stimulation; Epilepsy; Intracerebral; Neuromodulation; Thalamus

Mesh:

Year:  2016        PMID: 27840024     DOI: 10.1016/j.ejpn.2016.10.011

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  7 in total

Review 1.  Surgical Treatment of Drug-Resistant Generalized Epilepsy.

Authors:  Katie L Bullinger; Abdulrahman Alwaki; Robert E Gross
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-17       Impact factor: 6.030

2.  The Child & Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation (CHILD-DBS).

Authors:  Han Yan; Lauren Siegel; Sara Breitbart; Carolina Gorodetsky; Hernan D Gonorazky; Ivanna Yau; Cristina Go; Elizabeth Donner; Suneil K Kalia; Alfonso Fasano; Alexander G Weil; Aria Fallah; George M Ibrahim
Journal:  Childs Nerv Syst       Date:  2020-09-15       Impact factor: 1.475

Review 3.  Invasive Neuromodulation for the Treatment of Pediatric Epilepsy.

Authors:  Laureen D Hachem; Han Yan; George M Ibrahim
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

4.  ASSFN Position Statement on Deep Brain Stimulation for Medication-Refractory Epilepsy.

Authors:  Abhijeet Gummadavelli; Dario J Englot; Jason M Schwalb; Chengyuan Wu; Jorge Gonzalez-Martinez; Joseph Niemat; Jason L Gerrard
Journal:  Neurosurgery       Date:  2022-05-01       Impact factor: 5.315

Review 5.  A Review of Neurostimulation for Epilepsy in Pediatrics.

Authors:  Keith Starnes; Kai Miller; Lily Wong-Kisiel; Brian Nils Lundstrom
Journal:  Brain Sci       Date:  2019-10-18

Review 6.  Neurostimulation as a promising epilepsy therapy.

Authors:  Yicong Lin; Yuping Wang
Journal:  Epilepsia Open       Date:  2017-08-23

7.  An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocol.

Authors:  Han Yan; Lauren Siegel; Sara Breitbart; Carolina Gorodetsky; Alfonso Fasano; Aliya Rahim; Alvin Loh; Abhaya V Kulkarni; George M Ibrahim
Journal:  Pilot Feasibility Stud       Date:  2022-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.